Lates News

According to a report by Reuters on April 25th, the latest report released by American drug research and pharmaceutical manufacturers association on the 22nd pointed out that the US government's tariff policy would lead to an increase in annual import costs in the pharmaceutical field by about $51 billion. These costs are likely to be passed on to American consumers, resulting in a roughly 12.9% increase in drug prices in the United States. In addition, the US government's tariff policy will also hinder the development of the American pharmaceutical industry, impact employment, and threaten the international competitiveness of the US pharmaceutical industry. (CCTV International News).